Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 30, 2023

Drug Sales Trends for AMPHETAMINE

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Payment Methods and Pharmacy Types for AMPHETAMINE (2020)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
INSIDE ANOTHER STORE	$1,262,771
INSIDE HMO/CLINIC/HOSPITAL	$453,973
[disabled in preview]	$1,100,557
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
INSIDE ANOTHER STORE	72,324
INSIDE HMO/CLINIC/HOSPITAL	26,001
[disabled in preview]	64,853
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$1,169,706
SELF OR FAMILY	$1,372,438
[disabled in preview]	$275,157
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for AMPHETAMINE

Drug Units Sold Trends for AMPHETAMINE

Annual Sales Revenues and Units Sold for AMPHETAMINE

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Try a Trial
Drug Name	Revenues (USD)	Units	Year
AMPHETAMINE	⤷ Try a Trial	⤷ Try a Trial	2019
AMPHETAMINE	⤷ Try a Trial	⤷ Try a Trial	2018
AMPHETAMINE	⤷ Try a Trial	⤷ Try a Trial	2017
AMPHETAMINE	⤷ Try a Trial	⤷ Try a Trial	2016
AMPHETAMINE	⤷ Try a Trial	⤷ Try a Trial	2015
AMPHETAMINE	⤷ Try a Trial	⤷ Try a Trial	2014
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

Mallinckrodt

Johnson and Johnson

AstraZeneca

Medtronic

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.